California Public Employees Retirement System decreased its position in shares of PAREXEL International Corporation (NASDAQ:PRXL) by 2.1% during the third quarter, Holdings Channel reports. The fund owned 145,800 shares of the company’s stock after selling 3,100 shares during the period. California Public Employees Retirement System’s holdings in PAREXEL International Corporation were worth $10,126,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the stock. FMR LLC boosted its stake in PAREXEL International Corporation by 122.1% in the second quarter. FMR LLC now owns 1,001,051 shares of the company’s stock valued at $62,946,000 after buying an additional 550,338 shares in the last quarter. Dalton Greiner Hartman Maher & Co. boosted its stake in PAREXEL International Corporation by 87.6% in the third quarter. Dalton Greiner Hartman Maher & Co. now owns 447,854 shares of the company’s stock valued at $31,103,000 after buying an additional 209,116 shares in the last quarter. BTIM Corp. purchased a new stake in PAREXEL International Corporation during the third quarter valued at about $14,463,000. Aberdeen Asset Management PLC UK boosted its stake in PAREXEL International Corporation by 25.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 998,811 shares of the company’s stock valued at $62,806,000 after buying an additional 201,812 shares in the last quarter. Finally, BB&T Corp boosted its stake in PAREXEL International Corporation by 535.1% in the second quarter. BB&T Corp now owns 128,777 shares of the company’s stock valued at $8,098,000 after buying an additional 108,499 shares in the last quarter. Institutional investors own 95.46% of the company’s stock.

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

PAREXEL International Corporation (NASDAQ:PRXL) opened at 71.25 on Friday. The stock has a 50 day moving average of $63.10 and a 200-day moving average of $64.91. The company has a market cap of $3.80 billion, a price-to-earnings ratio of 22.83 and a beta of 0.89. PAREXEL International Corporation has a one year low of $51.16 and a one year high of $72.32.

PAREXEL International Corporation (NASDAQ:PRXL) last announced its earnings results on Wednesday, October 26th. The company reported $0.76 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by $0.10. The business had revenue of $500.90 million for the quarter, compared to the consensus estimate of $525.15 million. PAREXEL International Corporation had a net margin of 7.09% and a return on equity of 30.71%. The business’s quarterly revenue was down 2.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.70 earnings per share. On average, equities analysts predict that PAREXEL International Corporation will post $3.74 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This news story was first published by Watch List News and is owned by of Watch List News. If you are reading this news story on another publication, it was stolen and republished in violation of US & international copyright and trademark legislation. The original version of this news story can be viewed at http://www.watchlistnews.com/california-public-employees-retirement-system-has-10126000-position-in-parexel-international-corporation-prxl/1061295.html.

PRXL has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of PAREXEL International Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, November 1st. Evercore ISI reiterated a “buy” rating and issued a $70.00 target price (down from $79.00) on shares of PAREXEL International Corporation in a research note on Saturday, October 29th. Robert W. Baird cut shares of PAREXEL International Corporation from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $78.00 to $67.00 in a research note on Thursday, October 27th. First Analysis cut shares of PAREXEL International Corporation from an “overweight” rating to an “equal weight” rating and set a $62.00 target price on the stock. in a research note on Thursday, November 17th. Finally, Jefferies Group lowered their target price on shares of PAREXEL International Corporation from $72.50 to $67.00 and set a “hold” rating on the stock in a research note on Thursday, October 27th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. PAREXEL International Corporation presently has a consensus rating of “Hold” and an average price target of $66.95.

PAREXEL International Corporation Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

5 Day Chart for NASDAQ:PRXL

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Corporation (NASDAQ:PRXL).

Receive News & Ratings for PAREXEL International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.